Exact Sciences
EXAS
#1992
Rank
C$10.69 B
Marketcap
$57.59
Share price
-1.61%
Change (1 day)
-33.85%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

Earnings for Exact Sciences (EXAS)

Earnings in 2024 (TTM): -C$1.45 Billion

According to Exact Sciences's latest financial reports the company's current earnings are C$2.75 Billion. a decrease over its 2023 earnings that were of -C$0.27 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Exact Sciences from 2001 to 2024

Annual earnings

Year Earnings Change
2024 -C$1.41 Billion435.08%
2023 -C$0.27 Billion-69.28%
2022 -C$0.86 Billion-25.55%
2021 -C$1.15 Billion1.68%
2020 -C$1.14 Billion271.17%
2019 -C$0.31 Billion58.99%
2018 -C$0.2 Billion20.89%
2017 -C$0.16 Billion-30.95%
2016 -C$0.23 Billion5.09%
2015 -C$0.22 Billion57.24%
2014 -C$0.14 Billion116.53%
2013 -C$64.13 Million
2011 -C$39.93 Million143.73%
2010 -C$16.39 Million27.85%
2009 -C$12.82 Million0.27%
2008 -C$12.78 Million-20.95%
2007 -C$16.17 Million-13.53%
2006 -C$18.7 Million-10.07%
2005 -C$20.79 Million-21.81%
2004 -C$26.59 Million-33.44%
2003 -C$39.95 Million-6.51%
2002 -C$42.73 Million17.95%
2001 -C$36.23 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-C$0.17 Billion-88.12%๐Ÿ‡บ๐Ÿ‡ธ USA
C$91.25 M-106.49%๐Ÿ‡บ๐Ÿ‡ธ USA
C$35.66 M-102.54%๐Ÿ‡บ๐Ÿ‡ธ USA
-C$48.44 Million-96.56%๐Ÿ‡บ๐Ÿ‡ธ USA
C$11.00 B-882.10%๐Ÿ‡ซ๐Ÿ‡ท France